ELAN vs. WGS
ELAN (Elanco Animal Health Incorporated) and WGS (GeneDx Holdings Corp.) are both stocks. Both are in the Healthcare sector — ELAN in Drug Manufacturers - Specialty & Generic, WGS in Health Information Services. Over the past 5 years, ELAN returned -6.39%/yr vs -33.09%/yr for WGS. At a 0.24 correlation, their price movements are largely independent.
Performance
ELAN vs. WGS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ELAN achieves a 8.57% return, which is significantly higher than WGS's -59.23% return.
ELAN
- 1D
- 3.98%
- 1M
- 9.15%
- YTD
- 8.57%
- 6M
- 10.78%
- 1Y
- 82.54%
- 3Y*
- 38.64%
- 5Y*
- -6.39%
- 10Y*
- —
WGS
- 1D
- -0.21%
- 1M
- -21.95%
- YTD
- -59.23%
- 6M
- -66.94%
- 1Y
- -27.18%
- 3Y*
- 101.82%
- 5Y*
- -33.09%
- 10Y*
- —
ELAN vs. WGS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
ELAN Elanco Animal Health Incorporated | 8.57% | 86.87% | -18.72% | 21.93% | -56.94% | -7.47% | -3.28% |
WGS GeneDx Holdings Corp. | -59.23% | 69.22% | 2,694.91% | -68.41% | -94.09% | -59.60% | 12.65% |
Correlation
The correlation between ELAN and WGS is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.18 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.16 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.25 |
Correlation (All Time) Calculated using the full available price history since Nov 5, 2020 | 0.24 |
Fundamentals
ELAN:
$12.43B
WGS:
$1.56B
ELAN:
-$0.48
WGS:
-$2.71
ELAN:
2.51
WGS:
3.44
ELAN:
1.91
WGS:
6.12
ELAN:
$4.89B
WGS:
$442.68M
ELAN:
$2.42B
WGS:
$302.56M
ELAN:
$755.00M
WGS:
-$51.08M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ELAN vs. WGS — Risk / Return Rank
ELAN
WGS
ELAN vs. WGS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Elanco Animal Health Incorporated (ELAN) and GeneDx Holdings Corp. (WGS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ELAN | WGS | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.92 | -0.33 | +2.25 |
Sortino ratioReturn per unit of downside risk | 2.73 | 0.14 | +2.59 |
Omega ratioGain probability vs. loss probability | 1.35 | 1.02 | +0.33 |
Calmar ratioReturn relative to maximum drawdown | 3.16 | -0.34 | +3.51 |
Martin ratioReturn relative to average drawdown | 10.42 | -0.74 | +11.16 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ELAN | WGS | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.92 | -0.33 | +2.25 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.14 | -0.30 | +0.16 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.11 | -0.26 | +0.15 |
Drawdowns
ELAN vs. WGS - Drawdown Comparison
The maximum ELAN drawdown since its inception was -78.00%, smaller than the maximum WGS drawdown of -99.85%. Use the drawdown chart below to compare losses from any high point for ELAN and WGS.
Loading charts...
Drawdown Indicators
| ELAN | WGS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -78.00% | -99.85% | +21.85% |
Max Drawdown (1Y)Largest decline over 1 year | -26.23% | -79.40% | +53.17% |
Max Drawdown (3Y)Largest decline over 3 years | -56.10% | -84.28% | +28.18% |
Max Drawdown (5Y)Largest decline over 5 years | -78.00% | -99.73% | +21.73% |
Current DrawdownCurrent decline from peak | -33.09% | -93.78% | +60.69% |
Average DrawdownAverage peak-to-trough decline | -39.81% | -83.36% | +43.55% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.95% | 36.97% | -29.02% |
Volatility
ELAN vs. WGS - Volatility Comparison
The current volatility for Elanco Animal Health Incorporated (ELAN) is 22.67%, while GeneDx Holdings Corp. (WGS) has a volatility of 72.31%. This indicates that ELAN experiences smaller price fluctuations and is considered to be less risky than WGS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ELAN | WGS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 22.67% | 72.31% | -49.64% |
Volatility (6M)Calculated over the trailing 6-month period | 32.65% | 83.67% | -51.02% |
Volatility (1Y)Calculated over the trailing 1-year period | 43.12% | 83.86% | -40.74% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 45.57% | 109.84% | -64.27% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 44.20% | 107.46% | -63.26% |
Dividends
ELAN vs. WGS - Dividend Comparison
Neither ELAN nor WGS has paid dividends to shareholders.
Financials
ELAN vs. WGS - Financials Comparison
This section allows you to compare key financial metrics between Elanco Animal Health Incorporated and GeneDx Holdings Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ELAN vs. WGS - Profitability Comparison
ELAN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Elanco Animal Health Incorporated reported a gross profit of 785.00M and revenue of 1.37B. Therefore, the gross margin over that period was 57.3%.
WGS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, GeneDx Holdings Corp. reported a gross profit of 68.21M and revenue of 102.25M. Therefore, the gross margin over that period was 66.7%.
ELAN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Elanco Animal Health Incorporated reported an operating income of 307.00M and revenue of 1.37B, resulting in an operating margin of 22.4%.
WGS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, GeneDx Holdings Corp. reported an operating income of -57.47M and revenue of 102.25M, resulting in an operating margin of -56.2%.
ELAN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Elanco Animal Health Incorporated reported a net income of 57.00M and revenue of 1.37B, resulting in a net margin of 4.2%.
WGS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, GeneDx Holdings Corp. reported a net income of -63.32M and revenue of 102.25M, resulting in a net margin of -61.9%.
Frequently Asked Questions
ELAN and WGS have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
WGS has higher volatility (72.31%) compared to ELAN (22.67%). In terms of maximum drawdown, ELAN dropped -78.00% vs WGS's -99.85%.
ELAN currently has the higher Sharpe Ratio (1.92 vs -0.33), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ELAN and WGS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer